According to BBC News, pharmaceutical company Novo Nordisk is expanding access to its weight-loss medication Wegovy by introducing a daily pill form in the United Kingdom. The tablet option complements the existing weekly injection, potentially appealing to patients who prefer oral medication over injections.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton